• Skip to main content
  • Skip to primary sidebar

Gold Coast Health & Knowledge Precinct

Transform with us

  • Home
  • About Us
    • Strategic Plan
    • Partners
      • City of Gold Coast
      • Griffith University
      • Gold Coast Health
      • Economic Development Queensland
      • Gold Coast Private Hospital
      • Cohort
      • Southport Sharks
    • Our people
    • Precinct Office
    • Map
    • Contact Us
  • Do Business
    • Investment Incentives
  • Live & Play
    • Australia’s Gold Coast
    • Residential – Smith Collective
    • Lifestyle – Retail and Recreation
  • Work & Study
  • Projects
    • Projects Overview
    • ADaPT
    • Clinical Entrepreneurship Change Agents Program
    • NeuTex Image-guided Surgery and Robotics Training Centre
  • Research
    • Overview
      • Additive Manufacturing
      • Biotechnologies
    • Research Institutes and Centres
    • Precinct experts
    • Research Equipment & Facilities
    • Clinical Trials
    • Health and medical training and conference hub
  • News
    • Latest News
    • Newsletter
    • Media
    • Video Channel
  • 中文
    • English
    • 中文

Filed Under: BUSINESS

Precinct attracts new company set to deliver a probiotics-based biotechnology bonanza

Dr Gustavo M Cerqueira at COHORT

Cluster Biotech could be the perfect name for a scale-up company that already has a cluster of commercialised and emerging technologies based on harnessing the microbial power of probiotics, all from new R&D headquarters at COHORT, in the GCHKP’s Lumina commercial cluster.

Multiple agricultural, industrial and human health applications

The average person may think of probiotics as the good bacteria that promote gut health – for Dr Gustavo Cerqueira and his team,  the potential of probiotics is virtually unlimited in agriculture, food safety and technology, waste and pest management, animal health, and now in a range of exciting new human therapeutic applications.

Hailing from Brazil, Dr Cerqueira was fortunate to undertake PhD studies through the prestigious Institut Pasteur in Paris, an ideal academic foundation for a microbiologist who is passionate about taking discoveries from lab to market.

“In searching for novel microbials we aim to use conventional discovery and genetic techniques to characterise new probiotics, which are micro-organisms sourced from nature including fungi, and put them to use in biotechnologies to preserve food, add nutritional value and reduce ingredient costs, enhance organic agriculture, and for use as hosts to deliver new biological-based human therapies and medical technologies,” Dr Cerqueira says.

“The Cluster Biotechnology team has a passion for solving real-life issues, and I can’t wait to see my staff create, collaborate and innovate to become a success story in the Precinct.”

Queensland Minister for State Development Hon Kate Jones and Member for Gaven Meaghan Scanlon MP meet some of the Cluster Biotech team

Arriving in Australia in 2011 as a research fellow at Monash University, before heading to James Cook University, Dr Cerqueira founded Cluster Biotech in 2015, based on industry demand for IP for specific solutions, such as Agriforte, the first probiotic pesticide used against fruit flies, and Agrisan, which prevents mould and fungal infection in crops.

He and his team have continued to develop their underlying discovery platform while patenting new applications – Foodsan, a probiotic biofilm spray, is their latest product undergoing pre-commercial trials in Norway and Ghana, aimed at preventing food spoilage and extending shelf-life and nutritional value.

“We hope it will extend opportunities for food exports from Australia and help to prevent food waste worldwide, while our project in Ghana shows the major opportunity to improve food security in Africa and elsewhere, where malnutrition continues to be such a big problem.”

With agricultural and industrial applications providing a fertile proving ground for their R&D, Cluster Biotech has recently entered into a joint venture arrangement with a major Australian Plastics player, which will help the industry partner diversify its repertoire of businesses, and jointly expand into the lucrative yet highly-regulated market of human health”

“We will be exploring opportunities in the medicinal cannabis field and we also believe we can use probiotic ‘biofactories’ to grow new anti-oxidants and anti-virals to be delivered as precision medicines and immune system therapies, while reducing the costs of treatment options.”

Another medtech application in the wings is a smart wound healing patch that it’s hoped will allow for remote monitoring of wound infection, with the slow release of healing doses of medication contained within the probiotic patch.

“Moving into our new labs in the Gold Coast Health and Knowledge Precinct gives us the first-class facilities to really focus on human health as our previous premises were set up for industrial R&D, and we’re eager to be able to meet Australia’s strict TGA requirements to develop new products that will be readily accepted worldwide.”

Read more about the move into COHORT and their exciting new lab spaces.

Precinct partnerships planned

“We look forward to finding research partnership opportunities with Griffith University and engaging their research students and talent – this is the ideal environment for our growth.”

Cluster Biotech hopes to expand its current core group of up to 10 staff and collaborators, to a 50 strong global team within the next 3-5 years.

May 27, 2020 By Kathy Kruger

Filed Under: BUSINESS

COHORT proves great global base for compliance software company

Virtual Mgr's Business Analyst, Georgia Rissman and CEO Anil Patel. Image: Nigel Hallett, Courier Mail

Lifestyle lured Virtual Mgr co-founder and CEO Anil Patel to the Gold Coast seven years ago with a great business idea – app-based software that enables companies to manage risk and maintain staff compliance across multiple locations and a range of operational areas, such as food handling and environmental services in healthcare.

It’s been a stunning story of success since, with revenue expected to jump by 400% in the coming year and staff numbers set to double.

After building a local base of major clients including Village Roadshow Theme Parks and the University of Queensland, the business began expanding into both the US and UK, and with the move of the core strategy and sales team into COHORT last year the growth trajectory has accelerated, particularly into the lucrative US hospital and healthcare market.

The rapid scale-up is being assisted by the rich environment of innovation offered at COHORT, which provides Anil and his team with ready access to fellow entrepreneurs as well as students and skills, and crucial exposure to government.

“Being based in COHORT has really been useful at this stage in our global growth as we’ve had great access to government, including Ministers at different events,” Anil says.

We’ve had two interns through Griffith University and are currently recruiting a PhD student to expand our data science R&D as we continue to develop our products to not only effectively manage risk and compliance, but use AI machine learning to help clients predict and avoid non-compliance incidents.”

“We’ve also been able to give back to the innovation eco-system by mentoring start-ups since we are now further along in our business maturity.”

With a background in the high-risk petroleum industry managing compliance incidents across multiple service stations, and having to rely on manual procedures in the era of fax communication, Anil recognised the opportunity for software to provide a better management solution and saw the need to develop a ‘simple’ app-based interface to ensure front line staff could more easily and effectively comply with standards.

Having proved the concept through developing solutions for dangerous goods transport, remote asset management and associated occupational health and safety requirements with clients including Caltex and BP, the company turned its attention to other high-risk areas including food safety, commercial cleaning and cleaning services within hospitals.

And they aimed high – entering the highly-litigious US market with a cloud-based health product that enables environmental services staff to execute step-by-step cleaning tasks for infection control compliance, while incorporating training and policy information, tracking assets and issues and providing managers with rich data on staff performance, workflow and risk mitigation.

They secured a Tier 1 hospital in Rochester, New York as their first client and haven’t looked back, with their biggest contract to date with global facilities management company Compass PLC that will see Virtual Mgr deployed in up to 800 US hospitals, led by their CEO North America, Tony Morocco.

“This is a major opportunity for us and will see our global staff accelerate from just under 30 now to up to 70 people within the next 1-2 years,” Anil says.

Virtual Mgr will focus on the US where technology take-up is high, along with the UK and their emerging market in Canada, while the high-risk cruise ship industry is another target, alongside the Asian market.

Expanding the tech in their products is another key focus, with increasing use of sensor and IoT technologies particularly to ensure temperature control for food safety, and enhanced real time data analytics for incident management.

Founding partner and tech guru Neil Fillingham remains Melbourne-based, along with a number of developers, and the US will see the most significant staff growth, but the GCHKP is set to provide a long-term HQ for the innovative company.

COHORT programs expand as 1 year anniversary approaches

Still within its first year of operation, COHORT will expand its program offering in 2020, launching a ‘lunch ‘n’ learn’ program from February 13, while the 2020 Mentoring program is set to commence from March ahead of the first anniversary in April.

Programs include:

  • Business Health Check – for all new members to get their business revving
  • Experts Program –  business advice series with high-profile industry entrepreneurs and professionals delivered in a lunch ‘n learn group session once a month.
  • The COHORT mentorship program is aimed at bringing together promising young entrepreneurs managing rapidly growing companies with already experienced and established entrepreneurs, with members entitled to up to 3 mentoring sessions from a pool of mentors.
  • Digital workshops – part of the national ASBAS program, COHORT hosts a range of digital workshops that are seriously subsidised by the Australian Government to get SME’s more digitally capable in focus areas including websites and online selling, social media, small business software and security.

There are still places available in the highly-regarded Women in AI program, which includes a 6-day camp and year-long mentoring for young women leaders in data science.

While available private offices are currently fully utilised, there are a range of flexible packages for co-working desks in the heart of the Precint’s Lumina commercial cluster.

February 5, 2020 By Kathy Kruger

Filed Under: BUSINESS, HEALTH Tagged With: China, drug discovery, Grand Pharma, Institute for Glycomics

Landmark drug development deal with China for block-buster drug

Institute for Glycomics Director Professor Mark von Itzstein AO signs the agreement watched by Griffith University Vice Chancellor and President Professor Carolyn Evans

Griffith University’s Institute for Glycomics has partnered with Hong Kong listed China Grand Pharma’s newly established Australian company Grand Medical Ltd to develop a new drug for Human Parainfluenza Virus.

Human parainfluenza virus (hPIV) commonly causes upper and lower respiratory illnesses in infants, young children, the elderly, and people with weakened immune systems, including transplant patients, however anyone can get infected. Respiratory tract infections remain the deadliest communicable diseases worldwide, causing more than 3.2 million deaths in 2015 alone.

Currently there is no therapeutic available to specifically treat hPIV infection, with the potential for the Institute’s new drug to be a global block-buster.

Biggest deal of its kind for an Australian University

“This multimillion-dollar agreement represents Australia’s largest preclinical stage university engagement with Pharma to discover a novel antiviral drug and reflects our strong scientific team and IP portfolio”.

Dr Chris Davis, General Manager, Institute for Glycomics

Professors Mark von Itzstein and Carolyn Evans with Dr Linda Shi (Grand Medical Ltd) and Dr Michael Wang (China Grand Pharma)

The deal comprises significant upfront Research & Development and licence fees plus development and sales milestone fees with a tiered royalty on product sales.

China Grand Pharma has made major investments in several international companies including an Australian company Sirtex Medical Pty Ltd, German company Cardionovum GmbH and Canadian company Conavi Medical Inc.

READ MORE

December 5, 2019 By Kathy Kruger

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Go to Next Page »

Primary Sidebar

Recent Posts

  • Healthtech Summit celebrates a future of personalised medicine, AI and hope
  • From Research to Reality: GCHKP Talent Leads the LuminaX 2025 Cohort
  • A New Era of Health and Tech Innovation: HATRIC to Transform the Gold Coast
  • Clinician Entrepreneurship Program wraps as a big success
  • 2025 International Women’s Day
  • International Women’s Day event 2025
  • Associate Prof Lara Herrero leading the fight against mosquito-borne diseases and advancing medical research
  • INVEST-FEST accelerates founder funding
  • Student innovation incubator set to launch in 2025
  • World-first clinical trial for treating spinal cord injury

Archives

  • June 2025
  • April 2025
  • March 2025
  • February 2025
  • November 2024
  • October 2024
  • September 2024
  • July 2024
  • May 2024
  • April 2024
  • January 2024
  • December 2023
  • October 2023
  • September 2023
  • August 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • October 2022
  • August 2022
  • July 2022
  • May 2022
  • March 2022
  • February 2022
  • November 2021
  • October 2021
  • August 2021
  • July 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • March 2020
  • February 2020
  • December 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • January 2019
  • December 2018
  • October 2018
  • August 2018

Subscribe to our newsletter and we’ll update you on all that’s new in our Precinct.

Latest News

Healthtech Summit celebrates a future of personalised medicine, AI and hope image

Healthtech Summit celebrates a future of personalised medicine, AI and hope

Read More >

From Research to Reality: GCHKP Talent Leads the LuminaX 2025 Cohort image

From Research to Reality: GCHKP Talent Leads the LuminaX 2025 Cohort

Read More >

A New Era of Health and Tech Innovation: HATRIC to Transform the Gold Coast image

A New Era of Health and Tech Innovation: HATRIC to Transform the Gold Coast

Read More >

Clinician Entrepreneurship Program wraps as a big success image

Clinician Entrepreneurship Program wraps as a big success

Read More >

2025 International Women's Day image

2025 International Women's Day

Read More >

International Women's Day event 2025 image

International Women's Day event 2025

Read More >

Before Footer

Search

Asia-Pacific’s emerging health and innovation hub, the 200-hectare Gold Coast Health & Knowledge Precinct (GCHKP) is a unique global business location for high-tech industry development, research collaboration and jobs of the future.

  • Home
  • About Us
  • Precinct Map
  • News
  • Do Business
  • Work & Study
  • Partners
  • Projects
  • Research
  • Contact Us
  • Privacy Policy
  • Sitemap
  • Subscribe
  • Facebook
  • LinkedIn
  • YouTube

© 2025 Gold Coast Health and Knowledge Precinct. All rights reserved.

Designed and Developed by Stead Lane